Evidence map›Paper›PMID 35062769›Full record

ArticleVaccines2022

Development and Properties of

Vitaly Pavlov, Galina Vakhrameeva, Alexander Mokrievich, Mikhail E Platonov, Galina Titareva, Raisa Mironova, Tatiana Kombarova, Tatiana Gapelchenkova, Ivan Dyatlov

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Vitaly PavlovState Research Center for Applied Microbiology and Biotechnology (SRCAMB), 142279 Obolensk, Russia.ORCID 0000-0001-9107-5304
Galina VakhrameevaState Research Center for Applied Microbiology and Biotechnology (SRCAMB), 142279 Obolensk, Russia.
Alexander MokrievichState Research Center for Applied Microbiology and Biotechnology (SRCAMB), 142279 Obolensk, Russia.
Mikhail E PlatonovState Research Center for Applied Microbiology and Biotechnology (SRCAMB), 142279 Obolensk, Russia.
Galina TitarevaState Research Center for Applied Microbiology and Biotechnology (SRCAMB), 142279 Obolensk, Russia.
Raisa MironovaState Research Center for Applied Microbiology and Biotechnology (SRCAMB), 142279 Obolensk, Russia.
Tatiana KombarovaState Research Center for Applied Microbiology and Biotechnology (SRCAMB), 142279 Obolensk, Russia.
Tatiana GapelchenkovaState Research Center for Applied Microbiology and Biotechnology (SRCAMB), 142279 Obolensk, Russia.
Ivan DyatlovState Research Center for Applied Microbiology and Biotechnology (SRCAMB), 142279 Obolensk, Russia.
State Research Center for Applied Microbiology and Biotechnology · RU

Funding

the Ministry of Science and Higher Education of the Russian Federation 075-15.2019-1671
6 · The paper itself

Abstract

The genomic analysis of all subspecies

Indexed as

allelic exchangeBALB/c miceFrancisella tularensis 15 NIIEGin vitro and in vivo reproductionrecD gene

Identifiers

PMID35062769
PMCPMC8778684
OpenAlexW4205859574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.